-
Momelotinib, sold
under the
brand name
Ojjaara among others, is an
anticancer medication used for the
treatment of myelofibrosis. It is a J**** kinase...
- for Oral Use. Full
Prescribing Information". Pfizer, Inc. "Ojjaara (
momelotinib) Tablets, for Oral Use. Full
Prescribing Information". DailyMed. 15 September...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
- and who have
platelet (blood
clotting cells)
levels below 50,000/μL.
Momelotinib (Ojjaara) was
approved for
medical use in the
United States in September...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
-
under development for myelofibrosis. It is a deuterated-drug
analog of
momelotinib. Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling;...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
- JAK1
Abrocitinib Baricitinib Deuruxolitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2 Atiprimod...
